Zurueck zur Suche

Reporte zur Charge UJ696AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

18Reporte angezeigt
1Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
MI 3 VA 2 TN 2 FL 1 HI 1 CA 1 IL 1 MD 1 TX 1 AL 1 PA 1 ME 1

VAERS 2151177

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

kritisch
Staat
FL
Alter
16,0
Geschlecht
M
Eingang
01.03.2022
Impfdatum
25.02.2022
Beginn
26.02.2022
Tage bis Beginn
1,0
Dosis
5
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Activated partial thromboplastin time shortened Benzodiazepine drug level increased Blood fibrinogen Blood gases Blood pH decreased C-reactive protein increased Chest X-ray abnormal Coma scale Computerised tomogram head normal Cortical dysplasia Culture negative Electroencephalogram abnormal Endotracheal intubation Fibrin D dimer International normalised ratio normal Magnetic resonance imaging head normal Mechanical ventilation N-terminal prohormone brain natriuretic peptide normal

Symptomtext

At 6:50am on 02/26 (approximately 20 hours post immunization) patient was found by parents in bed with active seizures. EMS arrived and found patient with seizures. Transported to Medical Center. On arrival intermittent seizures with Glascow Coma Scale of 3. Electively intubated. Mechanically ventilated for 36 hours. Extubated on 02/27/22

Weitere VAERSDATA-Felder
Praegender Schweregrund
Coma scale
Hospital-Tage
-
Labordaten
Work up shows WBC 31.8k with 45S, 1B, 38L. Platelets 449k. Blood gas shows pH 7.17 with a base deficit of 12.2. PT 12.6. INR 1.1. PTT 39.1. D-Dimer 677. Fibrinogen 352. CRP 1.1. ESR 3. N-Pro NBT 44. Troponin <0.012. UA negative. COVID negative. Cultures negative. Tox screen negative except for benzodiazepine. CXR with possible RML infiltrate. CT scan of the brain negative. MRI of the brain in normal. Continuous video EEG is abnormal due to the presence of intermittent left frontotemporal slowing, often sharply contoured, admixed with the background in awake and sleep states. Findings indicate focal cortical dysfunction in this region.
Aktuelle Erkrankungen
COVID on 01/02/2022. URI symptoms with cough and congestion but no fever the week of 02/21/22
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2059216

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

kritisch
Staat
MI
Alter
3,0
Geschlecht
M
Eingang
24.01.2022
Impfdatum
17.01.2022
Beginn
23.01.2022
Tage bis Beginn
6,0
Dosis
UNK
Route/Site
IM / RL
Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Death

Symptomtext

Specific events unknown to this nurse. Child death was reported from local office with request for records from last 12 months including immunization records. Vaccines were given 6 days prior to death.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Death
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2360923

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

schwer
Staat
MI
Alter
3,0
Geschlecht
M
Eingang
07.07.2022
Impfdatum
17.05.2022
Beginn
17.06.2022
Tage bis Beginn
31,0
Dosis
1
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja
Crying Fall Haematoma Head injury Loss of consciousness

Symptomtext

A couple of minutes after receiving a flu vaccine, Patient was sitting in a chair. RN and mom ehard a "thud" on the heater vent and patient was on the floor. Mom immediately picked him up and he started to cry. Mom believes his head hit the vent and floor. Patient was alert and oriented, answering questions appropriately. Ice was placed on his forehead. Mom thinks he looked like he passed out. RN did not witness the fall to to position in the room. Patient had a hematoma on his forehead.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Loss of consciousness
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
Unknown
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
Unknown
Vorherige Impfungen
-

VAERS 1968659

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

schwer
Staat
HI
Alter
21,0
Geschlecht
F
Eingang
21.12.2021
Impfdatum
17.12.2021
Beginn
17.12.2021
Tage bis Beginn
0,0
Dosis
6
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Aphasia Bell's palsy COVID-19 Computerised tomogram normal Facial paralysis Herpes simplex test negative Magnetic resonance imaging normal Paraesthesia oral SARS-CoV-2 test positive Vulval ulceration

Symptomtext

She had COVID vaccine on 12/10/2021 then had flu vaccine on 12/17/2021. Patient started to feel tong tingling hours after she got influenza vaccine. She started to have difficulty talking and right sided facial drooping on the next day. She went to emergency department and got diagnosed as Bell's Palsy. She also got diagnosed COVID infection incidentally at ED.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Bell's palsy
Hospital-Tage
-
Labordaten
COVID positive on 12/18/2021. CT, MRI all normal to exclude stroke at Emergency department on 12/18/2021. Herpes PCR negative on 12/17/2021 at vulva from two 2mm sized ulcers. Waiting for Herpes IgG.
Aktuelle Erkrankungen
Possible HSV
Vorgeschichte
Corneal Abrasion
Andere Medikamente
Tri Sprintec 0.18/0.215/0.25mg/35mcg
Allergien
None
Vorherige Impfungen
-

VAERS 1830224

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

moderat
Staat
CA
Alter
28,0
Geschlecht
F
Eingang
29.10.2021
Impfdatum
28.10.2021
Beginn
28.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Hypoaesthesia Paraesthesia oral Pruritus Skin warm

Symptomtext

Arm felt itchy/warm and numb, tingling sensation in lips

Weitere VAERSDATA-Felder
Praegender Schweregrund
Paraesthesia oral
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
penicillin, possibly PEG
Vorherige Impfungen
-

VAERS 2210961

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
VA
Alter
0,8
Geschlecht
F
Eingang
01.04.2022
Impfdatum
-
Beginn
25.09.2021
Tage bis Beginn
-
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash

Symptomtext

a rash all over the child's body; Initial information received on 28-Mar-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 9 months old female patient who experienced a rash all over the body while receiving vaccines HEPATITIS B VACCINE and INFLUENZA QUADRIVAL A-B VACCINE [FLUZONE QIV]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On an unknown date, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B VACCINE (formulation, strength: unknown) lot UJ696AA in unknown administration site as immunization. On an unknown date, the patient received a dose of 0.25 ml of suspect HEPATITIS B VACCINE produced by unknown manufacturer (formulation, strength: unknown) lot number not reported in unknown administration site as immunization. The patient used the vaccines for the first time. On 25-SEP-2021 the patient developed a non-serious event a rash all over the child's body (rash) (unknown latency) following the administration of all suspect vaccines. Action taken was not applicable. The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Rash. At time of reporting, the outcome was Recovering / Resolving for the event.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2206556

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
VA
Alter
0,8
Geschlecht
F
Eingang
30.03.2022
Impfdatum
25.09.2021
Beginn
25.09.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt
Oral mucosal eruption Rash

Symptomtext

Child received Hep B and Fluzone on 9/25/2021. The same day developed rash, so parents took child to ER, was diagnosed: Nonspecific rash around mouth and trunk. Benadry (12.5mg/5ml) 7.875mg was given in the ER

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Child was sent to see Allergist by PCP
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1935763

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
IL
Alter
34,0
Geschlecht
F
Eingang
09.12.2021
Impfdatum
07.12.2021
Beginn
07.12.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Depressed level of consciousness Dizziness

Symptomtext

Light headed, Subconscious B/P: 120/76, 40, 86

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
NA
Vorgeschichte
NO
Andere Medikamente
Birth control, Prozac (antidepressant) , Liammotrigrine (Mood stabilized).
Allergien
NA
Vorherige Impfungen
-

VAERS 1867750

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
MD
Alter
21,0
Geschlecht
F
Eingang
13.11.2021
Impfdatum
12.11.2021
Beginn
12.11.2021
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Urticaria

Symptomtext

Patient called the pharmacy at about 1 pm, 1 hour after receiving the vaccine that she was experiencing "a reaction." Described hives/vague topical symptoms. I instructed patient to take oral Benadryl and to continue to monitor her symptoms. Instructed her to contact urgent care/emergency services if symptoms worsened. Patient said ok and hung up. I asked her to provide updates when she could. Followed up by phone with her 6 hours later, no answer. I left a voicemail asking for updates as soon as possible.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Urticaria
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
NONE REPORTED
Vorgeschichte
-
Andere Medikamente
-
Allergien
NONE REPORTED
Vorherige Impfungen
-

VAERS 1825670

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
TX
Alter
5,0
Geschlecht
F
Eingang
28.10.2021
Impfdatum
26.10.2021
Beginn
26.10.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Burning sensation Limb mass Rash Rash erythematous

Symptomtext

PT RECEIVED FLU VACCINE 10/26/2021 ON LEFT ARM, AND PT DEVELOPED LUMP WITH A RASH AFTER THE VACCINE, RASH CAN BE DESCRIBED AS RED AND BURNING.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1779594

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
MI
Alter
36,0
Geschlecht
M
Eingang
12.10.2021
Impfdatum
11.10.2021
Beginn
11.10.2021
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Abdominal discomfort Frequent bowel movements Pruritus Urticaria

Symptomtext

Received Flu Shot at work (hospital) around 1:00 pm. Developed GI discomfort and frequent stooling between 1:30 to 5:00 pm. At 8pm noticed itching on tops of feet. Woke up at 4 am to itching/hives on tops of both feet, around both armpits, and behind left knee. I've worked in healthcare for over a decade, have gotten my flu shot every year while working in healthcare, have gotten both sets of pfizer Covid vaccines (december 2020/jan 2021) and have never had a reaction to any vaccine previously.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
None
Vorgeschichte
Atrial Tachycardia (periodic, taking atenolol for) Irritable Bowel Syndrome
Andere Medikamente
Atenolol 25mg PO Daily
Allergien
None
Vorherige Impfungen
-

VAERS 1708693

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

mild
Staat
-
Alter
36,0
Geschlecht
M
Eingang
17.09.2021
Impfdatum
15.09.2021
Beginn
16.09.2021
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Arthralgia Chills Headache Injection site pain Pain in extremity

Symptomtext

injection site pain left and right arms beginning two hours after injection and worsening over the next 24 hours before gradually decreasing. Pain was worse in left arm versus right. Headache and chills around 3 AM the following morning post injection resolved within 3 hours. Significant right shoulder joint pain at 3 AM approximately 39 hours post injection. Pain was not relieved with 600mg Ibuprofen, stretching or postural changes. Pain eventually resolved spontaneously after about 2 hours.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Arthralgia
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2198788

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

gering
Staat
AL
Alter
0,5
Geschlecht
F
Eingang
25.03.2022
Impfdatum
23.03.2022
Beginn
23.03.2022
Tage bis Beginn
0,0
Dosis
2
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Inappropriate schedule of product administration

Symptomtext

given too early. first dose received 3/3/2022.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Inappropriate schedule of product administration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2151439

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ696AA

gering
Staat
PA
Alter
-
Geschlecht
M
Eingang
01.03.2022
Impfdatum
11.11.2021
Beginn
18.02.2022
Tage bis Beginn
99,0
Dosis
3
Route/Site
OT / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product use issue

Symptomtext

patient received 3 doses of FLUZONE QUADRIVALENT with no reported adverse event; Initial information from was received on 22-Feb-2022 regarding an unsolicited valid non-serious case received from other health professional via call center. This case involves a 1years old male patient who received 3 doses of Influenza USP trival A-B high dose subvirion vaccine [Fluzone senior] with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. Concomitant medications included Diphtheria vaccine toxoid, pertussis vaccine acellular, tetanus vaccine toxoid (DTAP) and Hepatitis a vaccine (Hepatitis A) for immunization. It was reported that the patient received first dose of suspect Influenza USP trival A-B high dose subvirion vaccine (batch number: UJ696AA) (formulation, lot number, strength, route of administration, administration site: unknown) on 11-Nov-2021, second dose on 20-Dec-2021 and third dose on 18-Feb-2022 (via intramuscular route in the right thigh) for immunization with no reported adverse event (product use issue). Action Taken: not applicable. It was not reported if the patient received a corrective treatment for the event (product use issue). At time of reporting, the outcome was Unknown for the event (product use issue). This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product use issue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
DTAP; HEPATITIS A
Allergien
-
Vorherige Impfungen
-

VAERS 1942873

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUAD QUADRIVALENT) · Charge UJ696AA

gering
Staat
TN
Alter
1,5
Geschlecht
F
Eingang
12.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

No adverse SE were reported or experienced by patient.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
None needed.
Aktuelle Erkrankungen
NA
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NKA
Vorherige Impfungen
-

VAERS 1942868

SEQIRUS, INC. · INFLUENZA (SEASONAL) (FLUAD QUADRIVALENT) · Charge UJ696AA

gering
Staat
TN
Alter
1,5
Geschlecht
F
Eingang
12.12.2021
Impfdatum
08.12.2021
Beginn
08.12.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LL
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event

Symptomtext

No adverse event or s/s of acute SE noted.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
NA
Aktuelle Erkrankungen
None
Vorgeschichte
NA
Andere Medikamente
NA
Allergien
NKA
Vorherige Impfungen
-

VAERS 1931717

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE) · Charge UJ696AA

gering
Staat
ME
Alter
88,0
Geschlecht
F
Eingang
08.12.2021
Impfdatum
25.10.2021
Beginn
19.11.2021
Tage bis Beginn
25,0
Dosis
2
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Extra dose administered Medication error

Symptomtext

patient received two doses of FLUZONE QUADRIVALENT this year with no adverse event; Initial information received on 30-Nov-2021 regarding an unsolicited valid non-serious case from an other health professional via Agency (under reference 00878749). This case involves an 88 years old female patient who received two doses of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED [FLUZONE] this year (extra dose administered). The patient's medical history, medical treatment(s), vaccination(s) and family history were not provided. The patient had no other concomitant vaccines The patient received 0.5 mL first dose of INFLUENZA QUADRIVAL A-B MULTIDOSE VACCINE PRESERVED (lot UJ696AA and expiration date: 30-Jun-2022) via intramuscular route in the left arm on 25-Oct-2021 and 0.5 mL second dose of same vaccine in the right arm on 19-Nov-2021 for prophylactic vaccination. It was a case of an actual medication error due to extra dose administered (same day latency). It was reported "Medical Assistant reported that a patient received two doses of FLUZONE QUADRIVALENT this year. The caller would like to know if there are any adverse events to monitor for and how to proceed. The first dose was administered on 25OCT2021 and the second dose was administered on 19NOV2021. The caller reported that the patient has not reported any adverse side effects or adverse events." At time of reporting, no adverse event reported. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 1742160

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE QUADRIVALENT) · Charge UJ696AA

gering
Staat
AZ
Alter
46,0
Geschlecht
F
Eingang
28.09.2021
Impfdatum
28.09.2021
Beginn
28.09.2021
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Confusional state Gaze palsy Mental status changes

Symptomtext

Approximately 10 minutes after receiving vaccine, patient exhibited altered mental status and confusion; eyes fixated upward and to the right for approximately 10-15 seconds. Patient was placed on O2 and EMS called immediately; this practitioner called her name to reorient her and was successful. She was able to answer simple questions at this time. Vitals signs stable when EMS arrived. Full assessment performed by EMS. Patient's son notified. He drove to office and drove her home. She was then notified by our office upon returning home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Confusional state
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
Baclofen, Duloxetine, Metoprolol, Naproxen, Nortriptyline, Omega-3 fatty acids
Allergien
Augmentin, Covid vaccine
Vorherige Impfungen
COVID vaccine